206 related articles for article (PubMed ID: 22494583)
21. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
22. c-Myc suppression of DNA double-strand break repair.
Li Z; Owonikoko TK; Sun SY; Ramalingam SS; Doetsch PW; Xiao ZQ; Khuri FR; Curran WJ; Deng X
Neoplasia; 2012 Dec; 14(12):1190-202. PubMed ID: 23308051
[TBL] [Abstract][Full Text] [Related]
23. DNA requirements for interaction of the C-terminal region of Ku80 with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs).
Radhakrishnan SK; Lees-Miller SP
DNA Repair (Amst); 2017 Sep; 57():17-28. PubMed ID: 28641126
[TBL] [Abstract][Full Text] [Related]
24. Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer.
Parrella P; Mazzarelli P; Signori E; Perrone G; Marangi GF; Rabitti C; Delfino M; Prencipe M; Gallo AP; Rinaldi M; Fabbrocini G; Delfino S; Persichetti P; Fazio VM
J Clin Pathol; 2006 Nov; 59(11):1181-5. PubMed ID: 16497868
[TBL] [Abstract][Full Text] [Related]
25. Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells.
Tsuji T; Katsurano M; Ibaragi S; Shima K; Sasaki A; Hu GF
Biochemistry; 2007 Aug; 46(31):8920-32. PubMed ID: 17630775
[TBL] [Abstract][Full Text] [Related]
26. Nonhomologous end joining repair pathway molecules as predictive biomarkers for patients with oral squamous cell carcinoma.
Joshi JS; Vora HH; Ghosh NR; Tankshali RN; Jetly DH; Trivedi TI
J Cancer Res Ther; 2021; 17(4):1031-1038. PubMed ID: 34528560
[TBL] [Abstract][Full Text] [Related]
27. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
[TBL] [Abstract][Full Text] [Related]
28. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
29. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
30. Percentage of positive biopsy cores: a better risk stratification model for prostate cancer?
Huang J; Vicini FA; Williams SG; Ye H; McGrath S; Ghilezan M; Krauss D; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1141-8. PubMed ID: 22099043
[TBL] [Abstract][Full Text] [Related]
31. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
[TBL] [Abstract][Full Text] [Related]
32. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
33. Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and bax downregulation in cervical carcinoma tumors.
Lloret M; Lara PC; Bordón E; Fontes F; Rey A; Pinar B; Falcón O
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):976-9. PubMed ID: 19251084
[TBL] [Abstract][Full Text] [Related]
34. Expression analysis of proteins involved in the non homologous end joining DNA repair mechanism, in the bone marrow of adult de novo myelodysplastic syndromes.
Economopoulou P; Pappa V; Kontsioti F; Papageorgiou S; Foukas P; Liakata E; Economopoulou C; Vassilatou D; Ioannidou ED; Chondropoulos S; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
Ann Hematol; 2010 Mar; 89(3):233-9. PubMed ID: 19727724
[TBL] [Abstract][Full Text] [Related]
35. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
[TBL] [Abstract][Full Text] [Related]
36. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
37. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks.
Uematsu N; Weterings E; Yano K; Morotomi-Yano K; Jakob B; Taucher-Scholz G; Mari PO; van Gent DC; Chen BP; Chen DJ
J Cell Biol; 2007 Apr; 177(2):219-29. PubMed ID: 17438073
[TBL] [Abstract][Full Text] [Related]
38. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.
Stumm L; Burkhardt L; Steurer S; Simon R; Adam M; Becker A; Sauter G; Minner S; Schlomm T; Sirma H; Michl U
J Clin Pathol; 2013 Jul; 66(7):563-8. PubMed ID: 23559350
[TBL] [Abstract][Full Text] [Related]
39. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer.
Weight CJ; Ciezki JP; Reddy CA; Zhou M; Klein EA
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):347-50. PubMed ID: 16545922
[TBL] [Abstract][Full Text] [Related]
40. Regulation of DNA repair mechanism in human glioma xenograft cells both in vitro and in vivo in nude mice.
Ponnala S; Veeravalli KK; Chetty C; Dinh DH; Rao JS
PLoS One; 2011; 6(10):e26191. PubMed ID: 22022560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
